GnuBIO Inks $10M
GnuBIO has raised $10 million in Series B financing, it announced Thursday. The funding will be used to commercialize the company’s desktop DNA sequencing platform. Specifics of the round were not released. GnuBIO is based in Cambridge, Mass.
5 October 2012•3 mins read
